It was recently suggested that knockdown of CXCR4 (with RNA interference or pharmacological inhibition with AMD3100) substantially limited orthotopic growth of breast cancer cells in vivo and prevented the development of macroscopically detectable metastases [30]. This evidence concerns the gene CXCR4 and breast cancer.